Accolade, Inc. (ACCD)
NASDAQ: ACCD · Real-Time Price · USD
7.00
+0.01 (0.07%)
Mar 31, 2025, 1:43 PM EDT - Market open
Accolade Market Cap
Accolade has a market cap or net worth of $573.54 million as of March 31, 2025. Its market cap has decreased by -22.01% in one year.
Market Cap
573.54M
Enterprise Value
585.54M
1-Year Change
-22.01%
Ranking
Category
Stock Price
$7.00
Market Cap Chart
Since July 2, 2020, Accolade's market cap has decreased from $1.40B to $573.54M, a decrease of -59.16%. That is a compound annual growth rate of -17.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 573.13M | 108.08% |
| Dec 31, 2024 | 275.44M | -69.92% |
| Dec 29, 2023 | 915.55M | 63.37% |
| Dec 30, 2022 | 560.40M | -68.11% |
| Dec 31, 2021 | 1.76B | -26.60% |
| Dec 31, 2020 | 2.39B | 70.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |